Merck KGaA (OTCMKTS:MKKGY) Issues Earnings Results

Merck KGaA (OTCMKTS:MKKGYGet Free Report) posted its quarterly earnings results on Thursday. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07, Zacks reports. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%.

Merck KGaA Price Performance

Shares of OTCMKTS MKKGY traded up $0.72 on Thursday, hitting $29.70. The company’s stock had a trading volume of 40,276 shares, compared to its average volume of 133,657. The stock has a 50 day moving average of $29.21 and a 200-day moving average of $32.03. The company has a market capitalization of $19.19 billion, a price-to-earnings ratio of 18.33, a price-to-earnings-growth ratio of 2.05 and a beta of 0.98. Merck KGaA has a 12-month low of $27.68 and a 12-month high of $39.17. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

Earnings History for Merck KGaA (OTCMKTS:MKKGY)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.